Leonardo Riella, MD, PhD
Leonardo Riella, MD, PhD
Medical Director of Kidney Transplantation
About Leonardo Riella, MD, PhD
Dr. Leonardo V. Riella is the Harold and Ellen Danser Endowed Chair in Transplantation at Massachusetts General Hospital, Harvard Medical School. He is the Medical Director of Kidney Transplantation and Senior Investigator at the Center of Transplantation Sciences. He completed his Internal Medicine Residency at BWH and his Nephrology and Transplantation Fellowship at the combined BWH and Massachusetts General Hospital Program.
His research has the goal of prolonging the life of transplanted organs by better detecting transplant rejection and applying novel treatments to re-educate the immune cells to tolerate the transplanted organ. Dr. Riella sees kidney patients both pre- and post-transplantation. He has special expertise in challenging cases such as antibody-mediated rejection and recurrence of glomerular disease.
Clinical Interests:
- Kidney (renal) transplant
- Kidney disease
- Immunology
- Immunocompromised patients
- Glomerulonephritis
- Glomerular disease
Treats:
- Adult
Languages:
- French, German, Italian, Portuguese, Spanish
Locations
Renal Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-5050
Medical Education
- MD, Federal University of Parana
- PhD, Federal University of Sao Paulo
- MD, Universidade Federal Do Parana
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital
- Fellowship, Brigham and Women's/Massachusetts General Joint Nephrology Fellowship
American Board Certifications
- Nephrology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Our bodies are constantly under attack by bacteria, viruses, fungi and parasites. In addition, sometimes our own cells proliferate out of control—as seen with cancer—or attack our own body—as seen with autoimmune diseases.
The immune system is our body’s army and protects us against all of the above enemies at all times. The immune system must be tightly regulated, since fighting an infection with too much ammunition may cause significant collateral damage. In 1995, one of the most critical immunological advances in the past 50 years occurred: the discovery of regulatory immune cells that inhibit the immune response, preventing it from getting out of control. We now know that there are many regulatory immune cells in our bodies that keeps the immune system under a tight control.
The Riella Laboratory is focused on understanding these mechanisms of immune regulation in order to develop smarter and more efficient ways to control the immune system and prevent organ rejection after transplantation.
Publications
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
#1 Research Hospital in America
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.